An Overview of Heme Biosynthesis

Heme is a coordination complex consisting of a porphyrin ring surrounding a single ferrous (Fe2+) or ferric (Fe3+) ion, able to bond with diatomic oxygen and transport it around the body.

hemeA heme group in a hemoglobin protein structure. Image Credit: Catalin Rusnac /

The capture or release of oxygen is based on pH, with a distal histidine residue located above the iron ion becoming protonated under acidic conditions (caused by high CO2, in fatigued muscles for example) and undergoing steric reorganization, releasing the oxygen. Without oxygen bound the iron is in the 2+ state, but is oxidized to Fe3+ once bound, meaning that oxygen is in the form of a superoxide ion (O2-) when bound.

Four heme subunits compose one hemoglobin protein, and oxygen binding with one subunit pulls the iron ion into line with the plane of the porphyrin ring that causes a conformational shift that disrupts inter-dimer bonds between subunits, putting the molecule in a “relaxed” state that more easily accepts additional oxygen molecules. In this way, the four heme subunits work together to maximize oxygen loading and unloading efficiency.

Heme biosynthesis

Heme is generated in most tissues, though principally in erythroid cells and by hepatocytes, the most common cell of the liver. There are a total of eight enzymes involved in heme synthesis, half of which are found in the mitochondria and cytosol, respectively. The overall reaction in the generation of heme is:

8 glycine + 8 succinyl-CoA + 5 O2 + Fe2+ -> Heme + 8 CoA + 4 NH4 + 14 CO2 + 2 H2O2 + 2 H+ + 11 H2O

This process is separated into a number of steps, mostly taking place within the mitochondria. The rate of each step is dependent on the tissue producing heme, though the first step of the synthesis of intermediate 5-aminolevulinate is usually considered rate-limiting. The enzyme aminolevulinic acid (ALA) synthase catalyzes this first step, allowing the condensation of glycine with succinyl-CoA to form ALA and CO2 in the mitochondrial matrix.

ALA is subsequently transported to the mitochondrial inner membrane space, it is thought by transport protein SLC25A38. A second enzyme, porphobilinogen (PBG) synthase, then catalyzes the condensation of two ALA molecules to form one molecule of PBG. Four PBG molecules are then bound in a linear formation, head to tail, assisted by hydroxymethylbilane (HMB) synthase.

Uroporphyrinogen (URO) synthase then aids in attaching the top head group to the bottom tail group of HMB, forming a ring. The final enzyme that was produced in the mitochondria, uroporphyrinogen decarboxylase, aids in the decarboxylation of the four pyrrole acetic acid side chains remaining on URO, forming coproporphyrinogen III.

Coproprphyrinogen III is next transported to the mitochondrial intermembrane space by ABCB6, an ATP-dependant transporter. Two of the remaining carboxylic acid side chains are removed from the molecule, converting it into protoporphyrinogen IX (PP) by CP oxidase, which is produced in the cytoplasm and is weakly associated with the exterior of the outside of the mitochondrial inner membrane. PP oxidase then catalyzes the reaction of PP with three molecules of oxygen to create protoporphyrin IX, producing three molecules of hydrogen peroxide as a by-product.

Finally, ferrous iron is inserted into the protoporphyrin IX macrocycle, catalyzed by ferrochelatase, which is synthesized in the cytoplasm and later is translocated to the mitochondrial matrix and inner mitochondrial membrane.

hemoglobinDiagram of oxygen transport in a blood cell. Image Credit: ShadeDesign /

Clinical significance

Heme is largely synthesized in erythroid cells for incorporation into hemoglobin, which consists of four heme proteins. The kidneys produce a hormone called erythropoietin that stimulates the production of heme in the bone marrow.

As mentioned, some heme is produced by cells of the kidney itself, though the synthesis is highly variable and tightly modulated, with the heme produced contributing towards the synthesis of a number of other biomolecules besides hemoglobin such as cytochrome P450. It is also used by the body as an iron reservoir, by a number of enzymes as an electron shuttle, and is involved in cellular respiration, differentiation, and proliferation.

A deficiency at any point in the mechanism of the production of heme may lead to the accumulation of intermediates resulting in a range of disorders known as porphyrias, which may be related to production in the erythroid cells (erythropoietic) or hepatocytes (hepatic).

The symptoms of porphyria include neurologic dysfunction and respiratory problems, depending on the intermediate accumulating within the body. A deficient ferrochelatase enzyme, for example, leads to the accumulation of protoporphyrin IX in erythrocytes, resulting in extreme photosensitivity that leaves sun-exposed skin irritated and swollen.

Heme Synthesis Pathway | Biochemistry


Further Reading

Last Updated: Jan 25, 2021

Michael Greenwood

Written by

Michael Greenwood

Michael graduated from the University of Salford with a Ph.D. in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.  


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Greenwood, Michael. (2021, January 25). An Overview of Heme Biosynthesis. News-Medical. Retrieved on July 20, 2024 from

  • MLA

    Greenwood, Michael. "An Overview of Heme Biosynthesis". News-Medical. 20 July 2024. <>.

  • Chicago

    Greenwood, Michael. "An Overview of Heme Biosynthesis". News-Medical. (accessed July 20, 2024).

  • Harvard

    Greenwood, Michael. 2021. An Overview of Heme Biosynthesis. News-Medical, viewed 20 July 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First-in-human trial shows safety and efficacy of CAR T cell therapy for advanced prostate cancer